Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Circulation
|
August 1, 1993
Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans
U Scherrer, P Vollenweider, D Randin, et al.
Circulation
|
June 1, 1994
Body fat and sympathetic nerve activity in healthy subjects
U Scherrer, D Randin, L Tappy, et al.
The Journal of Clinical Investigation
|
June 1, 1994
Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans
P Vollenweider, D Randin, L Tappy, et al.
The American Journal of Physiology
|
March 1, 1994
Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans
D Randin, P Vollenweider, L Tappy, et al.
The European Respiratory Journal
|
May 27, 2003
Increased eNO and pulmonary iNOS expression in eNOS null mice
S Cook, P Vollenweider, B Ménard, et al.
The New England Journal of Medicine
|
June 29, 1995
Suppression of alcohol-induced hypertension by dexamethasone
D Randin, P Vollenweider, L Tappy, et al.
Public Health Genomics
|
August 7, 2009
Strength of family history in predicting levels of blood pressure, plasma glucose and cholesterol
G Wandeler, F Paccaud, P Vollenweider, et al.
Revue Medicale Suisse
|
December 23, 2011
[CoLaus: diabetes and dyslipidemia, there is always something new!]
P Vollenweider, J Vaucher, F Bastardot, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 3, 2009
Obesity markers and estimated 10-year fatal cardiovascular risk in Switzerland
P Marques-Vidal, M Bochud, V Mooser, et al.
European Journal of Clinical Nutrition
|
September 29, 2011
The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used
P Marques-Vidal, S Velho, D Waterworth, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Circulation
|
August 1, 1993
Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans
U Scherrer, P Vollenweider, D Randin, et al.
Circulation
|
June 1, 1994
Body fat and sympathetic nerve activity in healthy subjects
U Scherrer, D Randin, L Tappy, et al.
The Journal of Clinical Investigation
|
June 1, 1994
Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans
P Vollenweider, D Randin, L Tappy, et al.
The American Journal of Physiology
|
March 1, 1994
Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans
D Randin, P Vollenweider, L Tappy, et al.
The European Respiratory Journal
|
May 27, 2003
Increased eNO and pulmonary iNOS expression in eNOS null mice
S Cook, P Vollenweider, B Ménard, et al.
The New England Journal of Medicine
|
June 29, 1995
Suppression of alcohol-induced hypertension by dexamethasone
D Randin, P Vollenweider, L Tappy, et al.
Public Health Genomics
|
August 7, 2009
Strength of family history in predicting levels of blood pressure, plasma glucose and cholesterol
G Wandeler, F Paccaud, P Vollenweider, et al.
Revue Medicale Suisse
|
December 23, 2011
[CoLaus: diabetes and dyslipidemia, there is always something new!]
P Vollenweider, J Vaucher, F Bastardot, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 3, 2009
Obesity markers and estimated 10-year fatal cardiovascular risk in Switzerland
P Marques-Vidal, M Bochud, V Mooser, et al.
European Journal of Clinical Nutrition
|
September 29, 2011
The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used
P Marques-Vidal, S Velho, D Waterworth, et al.
Page
of 9